The Effect of Doxycycline 100mg and Doxycycline 20mg in Treatment of Mild and Moderate Acne
Information source: Shaheed Beheshti Medical University
Information obtained from ClinicalTrials.gov on November 03, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Acne; Inflammation
Intervention: Doxycycline (Drug)
Phase: Phase 2/Phase 3
Status: Recruiting
Sponsored by: Shaheed Beheshti Medical University Official(s) and/or principal investigator(s):
Parviz Toossi, M.D., Principal Investigator, Affiliation: Shaheed Beheshti Medical University
Overall contact:
Parviz Toossi, M.D., Phone: 98-21-22744392, Email: src@sbmu.ac.ir
Summary
The purpose of this study is to compare the safety and efficacy of twice daily
subantimicrobial dose doxycycline 20mg with daily doxycycline 100mg in treatment of mild and
moderate Acne.
Clinical Details
Official title: The Effect of Doxycycline 100mg and Doxycycline 20mg in Treatment of Mild and Moderate Acne
Study design: Treatment, Randomized, Double-Blind, Dose Comparison, Parallel Assignment, Safety/Efficacy Study
Eligibility
Minimum age: 18 Years.
Maximum age: 40 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Acne
Exclusion Criteria:
- Pregnancy
Locations and Contacts
Parviz Toossi, M.D., Phone: 98-21-22744392, Email: src@sbmu.ac.ir
Skin Research Center, Shaheed Beheshti Medical University, Tehran 19899, Iran, Islamic Republic of; Recruiting
Parviz Toossi, M.D., Phone: 98-21-22744392, Email: src@sbmu.ac.ir
Parviz Toossi, M.D., Principal Investigator
Nahid Mohtasham, MD, Sub-Investigator
Additional Information
Starting date: October 2005
Ending date: October 2006
Last updated: January 22, 2008
|
